Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Iron Overload × Continuous Glucose Monitoring × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Other hematologic neoplasm 1 Lymphoid 1

Conditions

Prediabetic State 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Pituitary Neoplasms 1 Neoplasms 1 Lymphoma 1 Iron Overload 1 Hemoglobinopathies 1 Diabetes Mellitus, Type 2 1 Diabetes Mellitus, Type 1 1 Diabetes Mellitus 1 Cushing Syndrome 1 Colorectal Neoplasms 1 Bone Metastases 1

Interventions

Deferasirox 2 Glucose Tolerance Test 1 Deferoxamine 1 Continuous Glucose Monitoring 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03141398 2017-07-26

CGMs

Hamad Medical Corporation

LymphoidOther hematologic neoplasm

Hemoglobinopathies, Lymphoma, Iron Overload, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡